ID   SPAM-8
AC   CVCL_9V20
DR   Wikidata; Q54955519
RX   PubMed=1651784;
RX   PubMed=7590790;
RX   PubMed=7756584;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Heteromyeloma produced by the fusion of Sp2/0-Ag14 mouse myeloma with human peripheral blood lymphocytes (PubMed=1651784).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
RX   PubMed=1651784; DOI=10.3233/HAB-1991-2104;
RA   Gustafsson B., Jondal M., Sundqvist V.-A.;
RT   "SPAM-8, a mouse-human heteromyeloma fusion partner in the production
RT   of human monoclonal antibodies. Establishment of a human monoclonal
RT   antibody against cytomegalovirus.";
RL   Hum. Antibodies Hybridomas 2:26-32(1991).
//
RX   PubMed=7590790; DOI=10.1089/hyb.1995.14.265;
RA   Panova-Sapundjieva I., Gustafsson B.;
RT   "Increased human hybridoma formation by electrofusion of human B cells
RT   with heteromyeloma SPAM-8 cells.";
RL   Hybridoma 14:265-269(1995).
//
RX   PubMed=7756584;
RA   Gustafsson B., Hinkula J.;
RT   "Antibody production of a human EBV-transformed B cell line and its
RT   heterohybridoma and trioma cell line descendants in different culture
RT   systems.";
RL   Hum. Antibodies Hybridomas 5:98-104(1994).
//